AU2017217527A1 - Compositions and methods for treating chronic wounds - Google Patents

Compositions and methods for treating chronic wounds Download PDF

Info

Publication number
AU2017217527A1
AU2017217527A1 AU2017217527A AU2017217527A AU2017217527A1 AU 2017217527 A1 AU2017217527 A1 AU 2017217527A1 AU 2017217527 A AU2017217527 A AU 2017217527A AU 2017217527 A AU2017217527 A AU 2017217527A AU 2017217527 A1 AU2017217527 A1 AU 2017217527A1
Authority
AU
Australia
Prior art keywords
wound
healing
wounds
chronic
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017217527A
Other languages
English (en)
Inventor
Rummana ASLAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hackensack University Medical Center
Original Assignee
Hackensack University Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hackensack University Medical Center filed Critical Hackensack University Medical Center
Publication of AU2017217527A1 publication Critical patent/AU2017217527A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
AU2017217527A 2016-02-08 2017-02-08 Compositions and methods for treating chronic wounds Abandoned AU2017217527A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662292384P 2016-02-08 2016-02-08
US62/292,384 2016-02-08
PCT/US2017/017044 WO2017139398A1 (en) 2016-02-08 2017-02-08 Compositions and methods for treating chronic wounds

Publications (1)

Publication Number Publication Date
AU2017217527A1 true AU2017217527A1 (en) 2018-08-23

Family

ID=59563381

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2017217527A Abandoned AU2017217527A1 (en) 2016-02-08 2017-02-08 Compositions and methods for treating chronic wounds

Country Status (11)

Country Link
US (1) US20190046547A1 (https=)
EP (1) EP3413881B1 (https=)
JP (1) JP7026050B2 (https=)
AU (1) AU2017217527A1 (https=)
BR (1) BR112018016004A2 (https=)
CA (1) CA3013349A1 (https=)
CL (1) CL2018002128A1 (https=)
CO (1) CO2018008856A2 (https=)
ES (1) ES2883147T3 (https=)
IL (1) IL261010B (https=)
WO (1) WO2017139398A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL256312A (en) 2017-12-14 2018-01-31 Omrix Biopharmaceuticals Ltd Antibacterial preparations containing minocycline and oxidized cellulose
CN111228561A (zh) * 2020-01-13 2020-06-05 张新华 一种含中药基质的免涂抹创面敷料
AU2021325682A1 (en) * 2020-08-10 2023-03-02 Gel4Med, Inc. Antimicrobial matrix formed from peptide hydrogels
DE102020134827A1 (de) * 2020-12-23 2022-06-23 Paul Hartmann Ag Hydrogel zur Behandlung von Druckgeschwüren
AU2022220628A1 (en) * 2021-02-12 2023-09-07 Beth Israel Deaconess Medical Center Shape memory adhesive materials for diabetic wound healing
CN115040773B (zh) * 2022-06-22 2023-10-13 西南交通大学 一种治疗慢性感染创面的微针贴片及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401651A (en) * 1979-04-18 1983-08-30 Knutson Richard A Wound-healing compositions containing povidone-iodine
JPS6249848A (ja) * 1985-08-30 1987-03-04 三金工業株式会社 口腔内装着物
US5967979A (en) * 1995-11-14 1999-10-19 Verg, Inc. Method and apparatus for photogrammetric assessment of biological tissue
DE10031741A1 (de) * 2000-06-29 2002-01-17 Sanguibio Tech Ag Einen Sauerstoffträger, ausgewählt aus Hämoglobin oder Hämoglobin- und Myoglobin-enthaltende Zubereitung als Externum zur natürlichen Regeneration der Haut bei Sauerstoff-Mangel
KR100978905B1 (ko) * 2002-03-14 2010-08-31 가부시키가이샤 메드렉스 창상용 외용제
EP1576368B1 (en) * 2002-12-23 2009-02-18 William Marsh Rice Univeristy Methods and compositions for enhancing fibrocyte formation
US7731993B2 (en) * 2004-11-17 2010-06-08 Lindsey Berkson Composition for treating a dermal anomaly
US8440617B2 (en) * 2007-03-22 2013-05-14 The Trustees Of The University Of Pennsylvania Hyperbaric treatment in wound healing
DE102008031183A1 (de) * 2008-07-03 2010-01-07 Paul Hartmann Ag Wundauflage
EP2226073A1 (en) * 2009-03-02 2010-09-08 Euro-Celtique S.A. Topical pharmaceutical composition comprising an antiseptic and arginine for wound healing
US20110171284A1 (en) * 2010-01-11 2011-07-14 Gilman Miles E Povidone-iodine and sucrose wound healing dressing
US20130209592A1 (en) * 2012-02-13 2013-08-15 Steven C. Denstman Plant Extract Based Compositions and Methods For Treating Chronic Wounds
WO2014150174A1 (en) * 2013-03-15 2014-09-25 Mccord Darlene E Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
DE102013018565A1 (de) * 2013-10-28 2015-04-30 Gmbu E.V., Fachsektion Dresden Körperpflegemittel und dessen Verwendung

Also Published As

Publication number Publication date
EP3413881B1 (en) 2021-06-30
CA3013349A1 (en) 2017-08-17
BR112018016004A2 (pt) 2018-12-18
JP2019511468A (ja) 2019-04-25
WO2017139398A1 (en) 2017-08-17
EP3413881A1 (en) 2018-12-19
ES2883147T3 (es) 2021-12-07
EP3413881A4 (en) 2019-09-18
CL2018002128A1 (es) 2019-02-15
IL261010B (en) 2021-09-30
JP7026050B2 (ja) 2022-02-25
IL261010A (en) 2018-10-31
US20190046547A1 (en) 2019-02-14
CO2018008856A2 (es) 2018-09-10

Similar Documents

Publication Publication Date Title
EP3413881B1 (en) Compositions and methods for treating chronic wounds
Hall et al. Pathophysiologic mechanisms and current treatments for cutaneous sequelae of burn wounds
Das et al. Biomaterials and nanotherapeutics for enhancing skin wound healing
US20180303970A1 (en) Compositions and methods for healing wounds
BRPI0908149B1 (pt) Composição farmacêutica e curativo para o tratamento de lesões de pele, processo para a preparação do dito curativo, e uso de sal de cério associado a uma matriz de colágeno
JP6087917B2 (ja) 病理学的瘢痕の予防および治療のためのオリゴサッカライド化合物の使用
Raheem et al. Histological evaluation of effect of thymosin beta 4 on wound healing of skin
Sylakowski Therapeutic Strategies of Matricellular Proteins in Cutaneous Wound Healing: Countervailing Chronic Wounds and Excessive Scarring.
Scott et al. 051 Topical Oxygen Alters Angiogenesis‐Related Growth Factor Expression in Chronic Diabetic Foot Ulcers
Constantin et al. Wound repair-updates in dressing patents and regeneration biomarkers
Baronoski Integumentary anatomy: skin—the largest organ
Feldman et al. 037 Clinical evaluation of an electrical stimulation bandage (Posifect dressing)
KR20250058279A (ko) 피부 흉터 형성을 치료하기 위한 조성물 및 방법
Stechmiller et al. 052 Effect of Negative Pressure Wound Therapy on the Expression of TNF‐α, IL‐1β, MMP‐2, MMP‐3, and TIMP‐1 in Wound Fluid of Adults with Pressure Ulcers
Ennis et al. 036 MIST Ultrasound: The results of a multicenter, randomized, double‐blind, sham‐controlled trial of the healing of diabetic foot ulcers
Mooney et al. 031 Mechanical Characteristics of Fibroblast–Fibrin Constructs: Effect of Fibrinogen and Thrombin Concentration
Man et al. 065 Blockade of Rage with Lentiviral Gene Therapy Accelerates Healing in Diabetic Wounds Over Time
Janis et al. 071 Connective Tissue Growth Factor (CTGF) Content and Bioactivity of Small Intestinal Submucosa (SIS)
Margolis et al. 034 The Effectiveness of Topical Becaplermin for the Treatment of Diabetic Neuropathic Foot Ulcer
Huemer et al. 022 Extracorporal Shock Wave is More Effective than Gene Therapy with TGF‐Beta to Reduce Ischemic Necrosis in a Rat Epigastric Skin Flap Model
Copenhagen 7th Joint Meeting of the European Tissue Repair Society (ETRS) with the Wound Healing Society
Pirayesh et al. 054 The efficacy of polyhydrated ionogens in achieving stable wound closure in recalcitrant diabetic foot ulcers: A multicenter phase 1 pilot study
Gregory et al. 078 An ORC/Collagen Matrix ConTaining Silver and Microbial Imbalances in the Chronic Wound
Ayres et al. 012 Microvascular Endothelial Cell Migration in Scaffolds of Electrospun Collagen
Padgett et al. 046 AntiGlucocorticoid Effects of Androstenediol During Cutaneous Wound Healing

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application